Singular Health Group Ltd

ASX:SHG Stock Report

Market Cap: AU$23.8m

Singular Health Group Valuation

Is SHG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SHG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate SHG's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SHG's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SHG?

Key metric: As SHG is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for SHG. This is calculated by dividing SHG's market cap by their current revenue.
What is SHG's PS Ratio?
PS Ratio25.5x
SalesAU$934.07k
Market CapAU$23.78m

Price to Sales Ratio vs Peers

How does SHG's PS Ratio compare to its peers?

The above table shows the PS ratio for SHG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.2x
HIQ HITIQ
2.8xn/aAU$13.1m
IME ImExHS
0.7x20.5%AU$18.2m
DOC Doctor Care Anywhere Group
0.3x6.3%AU$25.3m
ADR Adherium
8.9x86.8%AU$7.5m
SHG Singular Health Group
25.5xn/aAU$23.8m

Price-To-Sales vs Peers: SHG is expensive based on its Price-To-Sales Ratio (25.5x) compared to the peer average (3.2x).

Price to Sales Ratio vs Industry

How does SHG's PS Ratio compare vs other companies in the AU Healthcare Services Industry?

7 CompaniesPrice / SalesEstimated GrowthMarket Cap
MDR MedAdvisor
1.4x13.4%US$107.81m
DOC Doctor Care Anywhere Group
0.3x6.3%US$16.50m
IME ImExHS
0.7x20.5%US$11.89m
VFX Visionflex Group
1.7xn/aUS$7.61m
SHG 25.5xIndustry Avg. 2.9xNo. of Companies7PS0816243240+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: SHG is expensive based on its Price-To-Sales Ratio (25.5x) compared to the Global Healthcare Services industry average (3x).

Price to Sales Ratio vs Fair Ratio

What is SHG's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SHG PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio25.5x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate SHG's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Doctor Care Anywhere Group

AU$25.3m

Provides digital healthcare and development services in the United Kingdom, Australia, and the Republic of Ireland.

DOC

AU$0.07

7D

4.5%

1Y

45.8%

CardieX

AU$32.4m

Engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific.

CDX

AU$0.11

7D

-24.1%

1Y

n/a

Cogstate

AU$170.8m

A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research.

CGS

AU$0.99

7D

4.2%

1Y

-35.5%